Unimedic Pharma is a fully integrated Swedish specialty pharma company with extensive experience in marketing, sales and drug development. We supply the Nordic region and northern Europe with a wide range of pharmaceuticals across several therapeutic areas. We continuously expand our product portfolio through long-term strategic partnerships, acquisitions of products and companies, and through drug development. By offering a diverse range of pharmaceuticals we strengthen our commitment to keep contributing to better health. Our in-depth knowledge and experience of the pharmaceutical markets in the Nordic region, combined with a robust company infrastructure, has established a successful track record of representing several other pharmaceutical companies as MAH or local representative in the area. At the company’s headquarters in Stockholm, there is a strong team that offers knowledge in Market Access, Marketing, Business Development, Supply Chain, Quality Assurance, Pharmacovigilance and Regulatory Affairs. Unimedic Pharma also offers business opportunities through out-licensing of our proprietary products to partners in markets outside the Nordic region.
There is no investment information
No recent news or press coverage available for Unimedic Pharma AB.